Medical Condition News

RSS

FDA meeting confirms Orexo regulatory submission of OX219 NDA on track

A meeting with the US regulatory agency FDA held on July 17 has confirmed that the Swedish pharmaceutical company Orexo is on track with its preparation for a regulatory submission of a new drug approval (NDA) for its medicine for treatment of opioid dependency, OX219.

23 Jul 2012

Research finds new gene involved in epilepsy

New research conducted by neuroscientists from the Royal College of Surgeons in Ireland (RCSI) published in Nature Medicine has identified a new gene involved in epilepsy and could potentially provide a new treatment option for patients with epilepsy.

23 Jul 2012

Noted philanthropist to launch mobile eye clinic in North India

Noted entrepreneur and philanthropist, Tej Kohli is all set to launch Drishti Rath, a complete eye clinic on wheels. After the successful launch of the corneal blindness eradication programme in 2010, which enabled hundreds of poverty stricken corneal blind to get vision and which is still running successfully across NCR and neighbouring rural areas, Tej is set to launch this first-of-its-kind initiative in North India.

23 Jul 2012

Linagliptin safe and effective for long-term management of type 2 diabetes

An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.

23 Jul 2012

Egg allergy treatment for children: an interview with Dr Robert Wood

The tendency to get allergies is a fairly general one, which is mostly inherited – it tends to run in families. There are several foods that are most common for children to become allergic to: milk, egg and peanuts in most countries are the most common food allergies.

23 Jul 2012

HIV drug resistance rates rising in some parts of Africa

New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.

23 Jul 2012

Computer program based on GLDM can improve accuracy in diagnosis of prostate cancer

Scientists in France have developed a computer program that can analyse in detail different shades of grey in medical images. Writing in a recent issue of the International Journal of Signal and Imaging Systems Engineering, they explain how the program based on the Grey Level Diﬀerence Method can improve accuracy in the diagnosis of prostate cancer.

23 Jul 2012

Researchers uncover protein structure that regulates blood cell formation and activity

A Finnish research team together with researchers from New York, USA, has uncovered a protein structure that regulates cell signalling and the formation of blood cells. The team's results, published in Nature Structural & Molecular Biology, the most prestigious journal in the field, shed light on the mechanisms at play in haematological disorders and provide new opportunities for the design of disease-specific treatment.

23 Jul 2012

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical Research Institute (FFBCRI) formerly known as the National Neurovision Research Institute (NNRI).

23 Jul 2012

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bayer HealthCare Pharmaceuticals, Onyx Pharmaceuticals, Inc., and Astellas Pharma Inc. today announced that a Phase 3 trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexavar (sorafenib) tablets did not improve overall survival for patients with unresectable hepatocellular carcinoma (HCC) vs. Nexavar alone.

23 Jul 2012

Targeting monocyte activation may reduce arterial inflammation in HIV-infected patients

The elevated risk of cardiovascular disease seen in patients infected with HIV appears to be associated with increased inflammation within the arteries, according to a study that will appear in a special issue of JAMA published in conjunction with the International AIDS Conference.

23 Jul 2012

Periodontal examination can determine risk of diabetes

A recent study published in the Journal of Dental Research at Columbia University College of Dental Medicine (CDM) and backed by The Jeffrey Epstein VI Foundation amongst others; found that a pre-diabetes determination can be made by simply going to the dentist.

23 Jul 2012

Researchers turn inanimate silicone and living cardiac muscle cells into a jellyfish

Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."

23 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

‘Disablism’ could shape the future for young people with a disability: University of Sydney research

A new study led by the University of Sydney hopes to shed light on how the experiences of young Australians with a disability are shaped by discrimination.

22 Jul 2012

Kyprolis for multiple myeloma receives FDA approval under accelerated approval program

The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.

21 Jul 2012

Exposure to high-intensity vibrations increases risk of Parkinson's

Severe influenza doubles the odds that a person will develop Parkinson's disease later in life, according to University of British Columbia researchers.

21 Jul 2012

FDA's approval of Kyprolis offers hope to myeloma patients, says IMF

The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.

21 Jul 2012

Antibody detects progenitor cells in cancers and cirrhosis of liver

The study, published in the journal Stem Cell, adds to our understanding of the role of stem and next stage progenitor cells in tissue regeneration and in the diagnosis and treatment of cancer.

21 Jul 2012

Study identifies genetic markers that influence protein involved in regulating oestrogen, testosterone levels

A research study led by the Peninsula College of Medicine and Dentistry, University of Exeter, and Boston University School of Medicine, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating oestrogen and testosterone levels in the bloodstream.

21 Jul 2012

Medical Condition News

FDA meeting confirms Orexo regulatory submission of OX219 NDA on track

Research finds new gene involved in epilepsy

Noted philanthropist to launch mobile eye clinic in North India

Linagliptin safe and effective for long-term management of type 2 diabetes

Egg allergy treatment for children: an interview with Dr Robert Wood

HIV drug resistance rates rising in some parts of Africa

Computer program based on GLDM can improve accuracy in diagnosis of prostate cancer

Researchers uncover protein structure that regulates blood cell formation and activity

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Targeting monocyte activation may reduce arterial inflammation in HIV-infected patients

Periodontal examination can determine risk of diabetes

Researchers turn inanimate silicone and living cardiac muscle cells into a jellyfish

BioDiem presents positive findings of their eye disease drug at international conference

‘Disablism’ could shape the future for young people with a disability: University of Sydney research

Kyprolis for multiple myeloma receives FDA approval under accelerated approval program

Exposure to high-intensity vibrations increases risk of Parkinson's

FDA's approval of Kyprolis offers hope to myeloma patients, says IMF

Antibody detects progenitor cells in cancers and cirrhosis of liver

Study identifies genetic markers that influence protein involved in regulating oestrogen, testosterone levels

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News